Caredx announces fourth quarter and full year 2023 financial results

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna) today reported financial results for the fourth quarter and full year ended december 31, 2023. fourth quarter and full year 2023 highlights reported full year revenue of $280.3 million, exceeding the high end of updated guidance for 2023. reported full year testing services revenue of $209.7 million and delivered approximately 165,700 patient results in 2023. grew testing services patient results for the second quarter in a row to a.
CDNA Ratings Summary
CDNA Quant Ranking